»óÇÇÁ¾ Ä¡·áÁ¦ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : Á¾·ùº°, ¾à¹° Á¾·ùº°, À¯Åë ä³Îº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2030³â)
Epithelioma Treatment Market Size, Share & Trends Analysis Report By Type, By Drug Class (Hedgehog Pathway Inhibitors, Immune Checkpoint Inhibitors), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
»óǰÄÚµå : 1654322
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2025³â 01¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 100 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,609,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,950 £Ü 10,055,000
Printable PDF (5-User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,949,000
Printable PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

»óÇÇÁ¾ Ä¡·áÁ¦ ½ÃÀå ¼ºÀå°ú µ¿Çâ:

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é, ¼¼°è »óÇÇÁ¾ Ä¡·áÁ¦ ½ÃÀå ±Ô¸ð´Â 2025³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 10.4%ÀÇ CAGRÀ» ±â·ÏÇÏ¿© 2030³â¿¡´Â 97¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÇǺξÏ, ƯÈ÷ ±âÀú¼¼Æ÷¾Ï(BCC)°ú ÆíÆò»óÇǾÏ(SCC)ÀÇ ¹ßº´·ü Áõ°¡°¡ ½ÃÀå È®´ëÀÇ ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. ¹Ì±¹ ¾ÏÇùȸ¿¡ µû¸£¸é, ¹Ì±¹¿¡¼­´Â 2024³â ¾à 100,640¸íÀÇ ½Å±Ô Èæ»öÁ¾ ȯÀÚ°¡ ¹ß»ýÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ±× Áß ³²¼ºÀº ¾à 59,170¸í, ¿©¼ºÀº ¾à 41,470¸íÀÔ´Ï´Ù. ¶ÇÇÑ, ³²¼º 5,430¸í, ¿©¼º 2,860¸í µî ¾à 8,290¸íÀÌ »ç¸ÁÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ·¯ÇÑ À¯º´·ü Áõ°¡´Â ÷´Ü Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¸¦ µÞ¹ÞħÇÏ¸ç ½ÃÀå ¼ºÀå¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù.

ÀÇ·á±â¼úÀÇ ¹ßÀüµµ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¸é¿ª°ü¹®¾ïÁ¦Á¦(¿¹: Æèºê·Ñ¸®ÁÖ¸¿, ´Ïº¼·ç¸¿)¿Í Ç¥Àû Ä¡·áÁ¦(¿¹: BCC¿¡ ´ëÇÑ ºñ½º¸ðµ¥Áöºê)¿Í °°Àº Çõ½ÅÀûÀÎ Ä¡·á¹ýÀÇ °³¹ßÀº Ä¡·á ¿É¼ÇÀ» º¯È­½Ã۰í, ȯÀڵ鿡°Ô »õ·Î¿î Èñ¸ÁÀ» ÁÖ¸ç, ½ÃÀå ±âȸ¸¦ È®´ëÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº ÀÌ·¯ÇÑ Ä¡·áÀÇ È¿°ú¿Í ¾ÈÀü¼ºÀ» °­Á¶ÇÏ´Â ¿ì¼öÇÑ ÀÓ»ó½ÃÇè °á°ú¿Í FDA ½ÂÀο¡ ÀÇÇØ µÞ¹ÞħµÇ°í ÀÖ½À´Ï´Ù.

±ÔÁ¦ ±â°ü°ú Á¤ºÎÀÇ ³ë·Âµµ ½ÃÀå Çü¼º¿¡ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ¹Ì±¹¿¡¼­´Â À¯¸ÁÇÑ Ä¡·á¹ý¿¡ ´ëÇÑ FDAÀÇ Á¶±â ½ÂÀÎ ÀýÂ÷°¡ »õ·Î¿î Ä¡·á¹ý¿¡ ´ëÇÑ ½Å¼ÓÇÑ Á¢±ÙÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ À¯·´¿¡¼­´Â À¯·´ÀǾàǰû(EMA)°ú °°Àº ÀÌ´Ï¼ÅÆ¼ºê°¡ ½Å¾à °³¹ß ¹× ½ÂÀο¡ Áß¿äÇÑ Áö¿øÀ» Çϰí ÀÖ½À´Ï´Ù. Á¤ºÎÀÇ ¾Ï ¿¬±¸ ÀÚ±Ý Áö¿ø°ú ´ëÁßÀÇ ÀÎ½Ä °³¼± Ä·ÆäÀÎÀº Á¶±â ¹ß°ß°ú Á¶±â Ä¡·á¸¦ °­È­ÇÏ¿© ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

»óÇÇÁ¾ Ä¡·áÁ¦ ½ÃÀå : ºÐ¼® °³¿ä

¸ñÂ÷

Á¦1Àå ºÐ¼® ¹æ¹ý¡¤¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå »óÇÇÁ¾ Ä¡·áÁ¦ ½ÃÀå : º¯¼ö, µ¿Çâ, ¹üÀ§

Á¦4Àå »óÇÇÁ¾ Ä¡·áÁ¦ ½ÃÀå : Á¾·ùº° ºñÁî´Ï½º ºÐ¼®

Á¦5Àå »óÇÇÁ¾ Ä¡·áÁ¦ ½ÃÀå : ¾à¹° Á¾·ùº° ºñÁî´Ï½º ºÐ¼®

Á¦6Àå »óÇÇÁ¾ Ä¡·áÁ¦ ½ÃÀå : À¯Åë ä³Îº° ºñÁî´Ï½º ºÐ¼®

Á¦7Àå »óÇÇÁ¾ Ä¡·áÁ¦ ½ÃÀå : Áö¿ªº° ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦8Àå °æÀï ±¸µµ

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Epithelioma Treatment Market Growth & Trends:

The global epithelioma treatment market size is expected to reach USD 9.73 billion by 2030, registering a CAGR of 10.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growing incidence of skin cancers, notably basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), is a major driver of market expansion. According to the American Cancer Society, the U.S. is expected to see approximately 100,640 new cases of melanoma in 2024, with around 59,170 in men and 41,470 in women. Additionally, melanoma is anticipated to cause about 8,290 deaths, including 5,430 men and 2,860 women. This escalating prevalence underscores the increasing demand for advanced treatments and contributes significantly to the market's growth.

Advancements in medical technology also play a crucial role. The development of innovative therapies, such as immune checkpoint inhibitors (e.g., pembrolizumab and nivolumab) and targeted therapies (e.g., vismodegib for BCC), has revolutionized treatment options, offering new hope for patients and expanding market opportunities. These advancements are further supported by positive clinical trial results and FDA approvals, which underscore the efficacy and safety of these treatments.

Regulatory bodies and government initiatives are also pivotal in shaping the market. In the U.S., the FDA's accelerated approval process for promising treatments facilitates faster access to new therapies. Additionally, initiatives like the European Medicines Agency (EMA) provide crucial support in developing and approving new drugs in Europe. Government funding for cancer research and public awareness campaigns are enhancing early detection and treatment, further driving market growth.

Epithelioma Treatment Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Epithelioma Treatment Market Variables, Trends, & Scope

Chapter 4. Epithelioma Treatment Market: Type Business Analysis

Chapter 5. Epithelioma Treatment Market: Drug Class Business Analysis

Chapter 6. Epithelioma Treatment Market: Distribution Channel Business Analysis

Chapter 7. Epithelioma Treatment Market: Regional Estimates & Trend Analysis

Chapter 8. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â